JAMA Dermatology Publishes Results from Verrica’s Two Pivotal Phase III CAMP (Cantharidin Application in Molluscum Patients) TrialsGlobeNewsWire • 09/23/20
VRCA Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Class Action Against Verrica Pharmaceuticals Inc. and Lead Plaintiff Deadline: September 14, 2020PRNewsWire • 09/14/20
DEADLINE TODAY: The Schall Law Firm Announces It Is Investigating Claims Against Verrica Pharmaceuticals Inc. and Encourages Investors with Losses of $100,000 to Contact the FirmBusiness Wire • 09/14/20
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Verrica Pharmaceuticals Inc.Business Wire • 09/11/20
DEADLINE MONDAY ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Verrica Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmNewsfile Corp • 09/11/20
VRCA Class Action Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Class Action Against Verrica Pharmaceuticals Inc. and Lead Plaintiff Deadline: September 14, 2020Newsfile Corp • 09/10/20
Deadline Reminder: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Verrica Pharmaceuticals Inc.PRNewsWire • 09/10/20
MONDAY DEADLINE NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Verrica Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmNewsfile Corp • 09/10/20
Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Verrica Pharmaceuticals Inc. (VRCA)PRNewsWire • 09/09/20
MONDAY DEADLINE REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Verrica Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmNewsfile Corp • 09/09/20
Verrica Pharmaceuticals Announces Participation in the H.C. Wainwright 22nd Annual Global Investment ConferenceGlobeNewsWire • 09/09/20
Lead Plaintiff Deadline Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In Verrica Pharmaceuticals Inc. To Contact The FirmNewsfile Corp • 09/08/20
MONDAY DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Verrica Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmNewsfile Corp • 09/08/20
VRCA Class Action Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Verrica Pharmaceuticals Inc. and Encourages Investors to Contact the FirmNewsfile Corp • 08/25/20
Verrica Pharmaceuticals Licenses LTX-315, A First-in-Class Oncolytic Peptide Based Immunotherapy, from Lytix Biopharma AS, for the Treatment of Dermatologic Oncology IndicationsGlobeNewsWire • 08/11/20
Verrica Pharmaceuticals: The Fundamentals Aren't So Clear, But The Stock Chart May Be Telling Us SomethingSeeking Alpha • 07/30/20
VRCA Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Verrica Pharmaceuticals Inc. and Encourages Investors to Contact the FirmNewsfile Corp • 07/24/20
Verrica Pharmaceuticals Announces Dr. Lawrence Eichenfield Joins Board of DirectorsGlobeNewsWire • 07/23/20
Verrica Pharmaceuticals Announces Clinical and Drug Development Leadership ChangesGlobeNewsWire • 07/23/20
VRCA Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Verrica Pharmaceuticals Inc. and Encourages Investors to Contact the FirmNewsfile Corp • 07/22/20
Verrica Deadline Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In Verrica Pharmaceuticals Inc. To Contact The FirmNewsfile Corp • 07/20/20
Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Verrica Pharmaceuticals, Inc. – VRCABusiness Wire • 07/17/20
SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Verrica Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmNewsfile Corp • 07/17/20
Shareholder Alert: Robbins LLP Announces Verrica Pharmaceuticals Inc. (VRCA) Accused of Misleading ShareholdersBusiness Wire • 07/16/20